{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:08:28Z","timestamp":1761512908048},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004602","name":"Program for New Century Excellent Talents in University","doi-asserted-by":"crossref","award":["NCET-10-0388"],"award-info":[{"award-number":["NCET-10-0388"]}],"id":[{"id":"10.13039\/501100004602","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.lungcan.2010.11.004","type":"journal-article","created":{"date-parts":[[2010,12,4]],"date-time":"2010-12-04T09:21:02Z","timestamp":1291454462000},"page":"110-115","source":"Crossref","is-referenced-by-count":28,"title":["Assessment of XPD Lys751Gln and XRCC1 T\u201377C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy"],"prefix":"10.1016","volume":"73","author":[{"given":"Li","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tangchun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaofa","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2010.11.004_bib0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0010","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14737159.8.6.761","article-title":"XRCC1 polymorphism and lung cancer risk","volume":"8","author":"Schneider","year":"2008","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0015","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1158\/1078-0432.CCR-07-1612","article-title":"Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis","volume":"14","author":"Yu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.lungcan.2008.03.005","article-title":"Oxiplatin doublets in non-small cell lung cancer: a literature review","volume":"60","author":"Cortinovis","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003495-200059004-00002","article-title":"Clinical perspectives on platinum resistance","volume":"59","author":"Giaccone","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1124\/pr.55.1.4","article-title":"Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer","volume":"55","author":"Danesi","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0169-5002(02)00224-6","article-title":"DNA repair and cisplatin resistance in non-small-cell lung cancer","volume":"38","author":"Rosell","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0045","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/jnci\/92.6.440","article-title":"DNA repair: a double-edged sword","volume":"92","author":"Wei","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/jnci\/djn437","article-title":"A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility","volume":"101","author":"Vineis","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0055","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/FPC.0b013e3280115e63","article-title":"Single nucleotide polymorphisms of the DNA repair gene XPD\/ERCC2 alter mRNA expression","volume":"17","author":"Wolfe","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0060","first-page":"604","article-title":"Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans","volume":"58","author":"Shen","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0065","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1158\/0008-5472.CAN-04-0372","article-title":"Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma","volume":"64","author":"Hao","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0070","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1038\/sj.onc.1209355","article-title":"A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer","volume":"25","author":"Hao","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0075","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ijc.11136","article-title":"Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population","volume":"105","author":"Liang","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0080","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/nar\/3.9.2303","article-title":"A general method for isolation of high molecular weight DNA from eukaryotes","volume":"3","author":"Blin","year":"1976","journal-title":"Nucleic Acid Res"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0085","first-page":"196","article-title":"[XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer]","volume":"28","author":"Yuan","year":"2006","journal-title":"Chin J Oncol"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0090","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","article-title":"XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy","volume":"22","author":"Gurubhagavatula","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<160::AID-IJC10>3.0.CO;2-J","article-title":"DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy","volume":"89","author":"van de Vaart","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0100","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1200\/JCO.2005.05.4171","article-title":"DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes","volume":"24","author":"Kennedy","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0105","first-page":"24","article-title":"Platinum-DNA adducts nucleotide excision repair and platinum based anti-cancer chemotherapy","author":"Reed","year":"1998","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/carcin\/21.3.453","article-title":"Nucleotide excision repair and human syndromes","volume":"21","author":"de Boer","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0115","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cell.2008.04.029","article-title":"Structure of the DNA repair helicase XPD","volume":"133","author":"Liu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1101\/gad.859501","article-title":"The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases","volume":"15","author":"Lehmann","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwi018","article-title":"ERCC2\/XPD gene polymorphisms and lung cancer: a HuGE review","volume":"161","author":"Benhamou","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/1471-2407-9-400","article-title":"XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk","volume":"9","author":"Long","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1471-2407-7-162","article-title":"Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain","volume":"7","author":"Lopez-Cima","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0140","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/carcin\/bgm020","article-title":"XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk","volume":"28","author":"Liu","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2005.12.026","article-title":"The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk","volume":"245","author":"Jiao","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0150","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/carcin\/bgh264","article-title":"Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer","volume":"25","author":"Popanda","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0155","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1289\/ehp.6632","article-title":"Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays","volume":"111","author":"Au","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/10409230802309905","article-title":"Base excision repair and its role in maintaining genome stability","volume":"43","author":"Baute","year":"2008","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7150\/ijms.4.59","article-title":"Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis","volume":"4","author":"Kiyohara","year":"2007","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.fpc.0000167329.85163.0d","article-title":"A promoter polymorphism (\u201377T>C) of DNA repair gene XRCC1 is associated with risk of lung cancer in relation to tobacco smoking","volume":"15","author":"Hu","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0175","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12253-008-9135-8","article-title":"Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report","volume":"15","author":"Syamala","year":"2009","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3816\/CLC.2009.n.015","article-title":"DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer","volume":"10","author":"Kalikaki","year":"2009","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0185","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2008.20.8793","article-title":"Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics","volume":"27","author":"Gandara","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0190","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1200\/JCO.2008.17.4839","article-title":"Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer","volume":"27","author":"Chew","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0195","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/FPC.0b013e32832f3010","article-title":"Cisplatin pharmacogenetics. DNA repair polymorphisms, and esophageal cancer outcomes","volume":"19","author":"Bradbury","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0200","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.tpj.6500463","article-title":"Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy","volume":"8","author":"Ruzzo","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0205","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.bjc.6604671","article-title":"Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin\/5-fluorouracil as first-line chemotherapy","volume":"99","author":"Pare","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jjco\/hyn130","article-title":"Prognostic significance of X-ray cross-complementing group 1 T-77C polymorphism in resected non-small cell lung cancer","volume":"39","author":"Hsieh","year":"2009","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0215","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1158\/1078-0432.CCR-06-2543","article-title":"Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer","volume":"13","author":"Giachino","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0220","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/1471-2407-9-439","article-title":"Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma","volume":"9","author":"Yin","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3322\/caac.20002","article-title":"Pharmacogenetics and pharmacogenomics of anticancer agents","volume":"59","author":"Huang","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0230","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/carcin\/bgl159","article-title":"Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions","volume":"28","author":"Manuguerra","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2010.11.004_bib0235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10555-009-9190-y","article-title":"Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications","volume":"28","author":"Wu","year":"2009","journal-title":"Cancer Metastasis Rev"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500210005386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500210005386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T12:22:33Z","timestamp":1544098953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500210005386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0169500210005386"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2010.11.004","relation":{},"ISSN":["0169-5002"],"issn-type":[{"type":"print","value":"0169-5002"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}